- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Public Companies
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Thomas K. Sprange, Q.C.
News 58 results
Recognition
October 21, 2021
King & Spalding Earns Multiple Rankings in Chambers UK 2022 Guide
Recognition
September 30, 2021
King & Spalding Earns Multiple Rankings in Legal 500 UK 2022 Guide
In the News · Source: Global Arbitration Review
September 27, 2021
John Savage QC, Tom Sprange QC and Simon Dunbar advise the IGE Group in an arbitration dispute with the RG Group
In the News · Source: Global Arbitration Review
Events 3 results
Speaking Engagement
December 9, 2020
Thomas Sprange QC, Isabel San Martin to Speak on ERA Pledge Young Practitioners Subcommittee Webinar
Speaking Engagement
Speaking Engagement
May 18, 2020
Thomas Sprange QC, Viren Mascarenhas to Speak on Webinar About COVID-19 Pandemic and Investment Arbitration
Insights 9 results
Article · Source: The Investment Treaty Arbitration Review
June 1, 2021
Enforcement of Awards
Article · Source: The Investment Treaty Arbitration Review
June 1, 2021
Treaty Interpretation In Investment Treaty Arbitrations
Client Alert
February 19, 2021
English High Court Rules That Compliance With Pre-Arbitration Negotiation Periods Incapable of Challenge on Jurisdictional Grounds
Client Alert
February 17, 2021
Enforcing the Level Playing Field in the EU-UK Trade and Cooperation Agreement